stockportfolio.pro
Establishment Labs Holdings Inc. (ESTA)
Healthcare · Medical Devices · NasdaqCM
Establishment Labs Holdings Inc. revenue & earnings — last 9 fiscal years
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $34.68M | $61.21M | $89.56M | $84.68M | $126.68M | $161.70M | $165.15M | $166.03M | $211.08M |
| Gross profit | $17.70M | $36.12M | $54.86M | $52.50M | $85.40M | $106.59M | $106.98M | $109.53M | $146.31M |
| Net income | $-34.90M | $-21.10M | $-38.15M | $-38.12M | $-41.14M | $-75.21M | $-78.50M | $-84.60M | $-51.06M |
| Net margin | -100.6% | -34.5% | -42.6% | -45.0% | -32.5% | -46.5% | -47.5% | -51.0% | -24.2% |
Source: Establishment Labs Holdings Inc. SEC filings (10-K).
Explore 9 years of Establishment Labs Holdings Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track ESTA in your portfolio →
Establishment Labs Holdings Inc. financial history by metric
About Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.
Establishment Labs Holdings Inc. — frequently asked questions
What is Establishment Labs Holdings Inc.'s revenue?
Establishment Labs Holdings Inc. (ESTA) reported revenue of $211.08M for fiscal year 2025, up 27.1% from the prior year, according to its SEC filings.
Is Establishment Labs Holdings Inc. profitable?
No — ESTA reported a net loss of $-51.06M in fiscal 2025.
What is ESTA's P/E ratio?
Establishment Labs Holdings Inc. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How fast is Establishment Labs Holdings Inc. growing?
ESTA's revenue grew at roughly 20.0% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Establishment Labs Holdings Inc. have?
As of fiscal year 2025, ESTA carried roughly $259.94M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Establishment Labs Holdings Inc.'s gross margin?
ESTA's gross margin was 69.3% in fiscal 2025 — gross profit of $146.31M on revenue of $211.08M.
What is Establishment Labs Holdings Inc.'s market cap?
Establishment Labs Holdings Inc. (ESTA) has a market capitalization of about $2.41B, based on the latest data in our nightly-refreshed cache.
When does Establishment Labs Holdings Inc.'s fiscal year end?
ESTA's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
Where does this data come from?
All figures are computed from Establishment Labs Holdings Inc.'s official SEC filings (10-K and 10-Q), covering 9 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.